From: Perception and attitude of Korean physicians towards generic drugs
Variables | Â | Answer | N | % |
---|---|---|---|---|
Knowledge | BE criteriaa | Not informed at all | 12 | 3.3 |
A little informed | 53 | 14.7 | ||
Moderately informed | 228 | 63.2 | ||
Completely informed | 68 | 18.8 | ||
Reliability | BE results | Not at all confident | 3 | 0.8 |
Not very confident | 79 | 21.9 | ||
Neutral | 186 | 51.6 | ||
Very confident | 90 | 24.9 | ||
Completely confident | 3 | 0.9 | ||
Perceptions | Safety and effectiveness compared to original | Non-equivalent | 192 | 53.2 |
Neutral | 106 | 29.3 | ||
Equivalent | 63 | 17.5 | ||
Main reasons for the negative recognition | Clinical experience | 116 | 32 | |
Confidence limit in BE test | 94 | 26 | ||
Confidence limit in generic | 94 | 26 | ||
Effect limit | 32 | 9 | ||
Evidence limit | 11 | 3 | ||
Others (minor opinion)* | 14 | 4 | ||
Price | Low price | 20 | 5.5 | |
Accurate price | 109 | 30.2 | ||
Over price | 232 | 64.3 | ||
Opinions | Reasonable price of generic | Same price as original | 11 | 3 |
80% of original | 93 | 25.8 | ||
70% of original | 95 | 26.3 | ||
60% of original | 85 | 23.5 | ||
Less than 50% of original | 77 | 21.3 | ||
Factors associated with the generic substitution (subjective response) | Same equivalent effects and safety as the original | 316 | 87.5 | |
Confidence of the pharmaceutical company | 34 | 9.4 | ||
Drug price | 8 | 2.2 | ||
Pharmaceutical marketing activity | 2 | 0.6 | ||
Hospital policy | 1 | 0.3 | ||
Factors to improve the generic prescription (multiple response b) | Quality maintenance of generic | 261 | 32.6 | |
BE confidence recovery | 216 | 26.9 | ||
Disclosure of the BE results | 193 | 24 | ||
Price cut | 88 | 10.9 | ||
Incentive policy | 41 | 5 | ||
Others | 5 | 0.6 | ||
Prescription behavior | If generic quality would be improved | Switch to the generic | 305 | 84.4 |
No change | 53 | 14.7 | ||
Switch to the original | 3 | 0.9 |